Clinical Trial Update: Evaluation of Lovastatin in Severe Persistent Asthma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating lovastatin for severe persistent asthma (Phase 1/2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: University of Chicago | Conditions: Severe Persistent Asthma | Phase 1, Phase 2 | Status: WITHDRAWN